A lost decade
Article
Successive governments have lauded the life sciences as a pillar of the UK economy in recent years. David Cameron talked about “a jewel in the crown”. Theresa May set out her ambition to make Britain “the global go-to place for scientists, innovators and tech investors”. And Boris Johnson has already committed to ‘supercharge’ UK science following Brexit.
There is optimism around the potential for growth in the industry – driven in no small part by a uniquely exciting moment for scientific advances.
However, new IPPR analysis shows that we have had a lost decade that has left one of our strongest sectors stagnating, even before accounting for its significant vulnerability to an unmanaged, no-deal Brexit.
In this briefing we set out key tests for policymakers looking to take the requisite steps to mitigate Brexit, as part of a strategy to support and invest in our life sciences industry.
Related items

Locked in: A realist's agenda for digital sovereignty
Digital sovereignty has never been more urgent.
Empowering people to hold tech accountable
We need reform to remove structural barriers to people and civil society taking direct action against tech companies in UK courts – putting more power in the hands of people.
Earned settlement: Decision time
The government is imminently due to announce plans for a new model of ‘earned settlement’. These are expected to represent the most significant reforms to indefinite leave to remain in a generation.